🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, CLOPIDOGREL, CLOPIDOGREL

    Fondazione Telethon ETS

    Patients with Stable or Unstable coronary syndromes who have undergone successful PCI

    approved small molecule active

    1 trial

  2. ACETYLSALICYLIC ACID, PRASUGREL

    Cardiol Therapeutics

    St-Elevated Myocardial Infartion

    approved small molecule active

    1 trial

  3. APOKYN

    SUPERNUS PHARMACEUTICALS, INC.

    Parkinson's Disease

    approved small molecule terminated

    2 trials

  4. ATORVASTATIN, PLACEBO

    Disc Medicine

    Atherosclerosis

    approved small molecule active

    1 trial

  5. Ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other terminated

    1 trial

  6. Access Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  7. Acetazolamide

    United Therapeutics Europe Ltd

    Hypobaric Hypoxia

    approved small molecule active

    1 trial

  8. Acetylsalicylzuur Aurobindo cardio 80 mg, tabletten.

    Disc Medicine

    ST elevation myocardial infarction (STEMI)

    approved small molecule active

    1 trial

  9. Advair HFA 230mcg/21mcg, Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab, Advair HFA 115 mcg/21 mcg

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  10. Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis I

    approved mab completed

    3 trials

  11. Alirocumab, Placebo product for REGN727

    The George Institute

    Cardiac allograft vaculopathy in recent heart transplant recipients

    approved small molecule active

    1 trial

  12. Aliskiren

    Novartis Pharmaceuticals

    Hypertension

    approved small molecule completed

    1 trial

  13. Amoxicillin 500 mg film-coated tablets, Placebo amoxicillin capsules 500mg

    Disc Medicine

    non-specific low back pain

    approved small molecule active

    1 trial

  14. Anti-Arrhythmics

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmia, Cardiac

    approved small molecule terminated

    1 trial

  15. Anti-hypertensive therapy

    Arrowhead Pharmaceuticals Ireland Limited

    Hypertension

    approved small molecule completed

    1 trial

  16. Arctic Front Advance Cardiac CryoAblation system

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial

  17. BH4

    BioMarin Pharmaceutical Australia Pty Ltd

    Pku Phenylketonuria

    approved small molecule active

    1 trial

  18. BILINDA GYNIAL 0,03 mg/2 mg Filmtabletten, Selina Gynial 0,03 mg/0,15 mg Filmtabletten

    Pari Pharma GmbH

    Hormonal contraception

    approved small molecule active

    1 trial

  19. BRONCHO-VAXOM® Kinder, 3,5 mg, Kapseln, Placebo to BRONCHO-VAXOM

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections with Wheezing Lower Respiratory Illness

    approved small molecule active

    1 trial

  20. Bevacizumab

    Arrowhead Pharmaceuticals Ireland Limited

    Pterygium

    approved small molecule completed

    1 trial

  21. Bilaxten Flas 10 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergic rhinoconjunctivitis

    approved small molecule active

    1 trial

  22. Botulinum Toxin Type B

    SUPERNUS PHARMACEUTICALS, INC.

    Cervical Dystonia

    approved mab completed

    1 trial

  23. Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe

    LEO Pharma A/S

    Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

    approved small molecule active

    1 trial

  24. CERITINIB

    Novartis Pharmaceuticals

    non small cell lung cancer

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources